class of diseases
new disease models
Experiments Acies Bio
Acies Bioâ€™s lead compound
alternative metabolic diseases
organism models
numerous rare metabolic diseases
Alzheimer's disease
existing models
fruit flies
field of CoA metabolism
class of compounds
phosphopantetheine-related compounds
metabolism related pathologies
disease model development
cellular CoA levels
innovative treatment
market approval
treatment available
Innovation Associate
range of Coenzyme
Innovation Strategy
open new opportunities
national labour market
state-of-the-art chemical synthesis
support facilities
outstanding coordination
patent protection
TIRCON consortium
prior recruitment of relevant expertise
analytics laboratory
novel phenotypic assays
untreatable conditions
diverse areas
wider population of patients
research
proof
suffering
obstacles
concept
common underlying cause
crucial step
pantothenate-kinase
drug discovery team
European Medicines Agency
medicinal product designation
associated neurodegeneration
High therapeutic potential
contribution
core
Launch of
diabetes
Successful completion
ground-breaking therapeutics
world leaders
PKAN
implications
valuable opportunity
dedicated facility
commercial environment
Application